<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">21810557</PMID>
        <DateCompleted>
            <Year>2011</Year>
            <Month>08</Month>
            <Day>30</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>12</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0949-2321</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>16</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2011</Year>
                        <Month>Jun</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>European journal of medical research</Title>
                <ISOAbbreviation>Eur J Med Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Induction maintenance concept for HAART as initial treatment in HIV infected infants.</ArticleTitle>
            <Pagination>
                <MedlinePgn>243-8</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Early initiated antiretroviral therapy (ART) in HIV infected infants leads to improved long-term viral suppression and survival. Guidelines recommend initiating therapy with a triple ART consisting of two nucleoside reverse transcriptase inhibitors (NRTIs) and either one additional non-nucleoside reverse transcriptase inhibitor (NNRTI) or a protease inhibitor (PI). Compared to older children and adults, viral relapse is seen more frequently in infants receiving triple ART. We now address the possibility of a more potent ART with a quadruple induction and triple maintenance therapy.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We examine the longitudinal course in four HIV infected infants, who were referred from other centers and could not be recruited to multicentre trials. We introduced ART initially consisting of two NRTIs, one NNRTI and one PI and later discontinued the PI at the age of 12 months maintaining a triple regime consisting of two NRTIs and one NNRTI.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Provided that therapy adherence was maintained we observed an effective sustained decline of viral load and significant CD4 cell reconstitution even after switching to a triple regime. No drug associated toxicity was seen.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We suggest that a four drug therapy might be a possible initial therapy option in HIV infected infants, at least in those with a high viral load, followed by a maintenance triple regime after 12 months of therapy.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ghosh</LastName>
                    <ForeName>Sujal</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital DÃ¼sseldorf, Medical Faculty, 40225 Duesseldorf, Germany. sujal.ghosh@med.uni-duesseldorf.de</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Neubert</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Niehues</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Adams</LastName>
                    <ForeName>O</ForeName>
                    <Initials>O</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Morali-Karzei</LastName>
                    <ForeName>N</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Borkhardt</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Laws</LastName>
                    <ForeName>H J</ForeName>
                    <Initials>HJ</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D023362">Evaluation Study</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Eur J Med Res</MedlineTA>
            <NlmUniqueID>9517857</NlmUniqueID>
            <ISSNLinking>0949-2321</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D023241" MajorTopicYN="N">Antiretroviral Therapy, Highly Active</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018791" MajorTopicYN="N">CD4 Lymphocyte Count</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018445" MajorTopicYN="N">Infectious Disease Transmission, Vertical</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2011</Year>
                <Month>8</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2011</Year>
                <Month>8</Month>
                <Day>4</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2011</Year>
                <Month>8</Month>
                <Day>31</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">21810557</ArticleId>
            <ArticleId IdType="pmc">PMC3353398</ArticleId>
            <ArticleId IdType="doi">10.1186/2047-783x-16-6-243</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2008 Nov 20;359(21):2233-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19020325</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2006 Aug 16;296(7):769-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16905783</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Infect Dis. 2009;9:140</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19709432</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>HIV Med. 2009 Nov;10(10):591-613</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19878352</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 2010 Jan 16;24(2):327-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20029271</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2011 Apr;11(4):273-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21288774</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1999 Dec 16;341(25):1874-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10601506</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Pediatr Adolesc Med. 2002 Jun;156(6):568-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12038889</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2003 Nov;112(5):973-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14610491</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 2004 Jan 23;18(2):237-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15075541</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2004 Jun 10;350(24):2471-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15190139</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1997 May 8;336(19):1337-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9134873</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Antimicrob Chemother. 2005 Feb;55(2):246-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15608053</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 2006 Jan 9;20(2):207-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16511413</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS. 2009 Mar 13;23(5):597-604</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19194272</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
